Home Healthcare Pharmaceuticals Atopic Dermatitis Market

Atopic Dermatitis Market Size, Share & Trends Analysis Report By Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), By Route of Administration (Topical, Parenteral, Oral), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Atopic Dermatitis Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Corticosteroids
    2. Calcineurin Inhibitors
    3. PDE4 Inhibitors
    4. Biologics
    5. Others
  2. Atopic Dermatitis Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Topical
    2. Parenteral
    3. Oral
  3. Atopic Dermatitis Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Atopic Dermatitis Market
    1. North America
      1. North America Atopic Dermatitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
      2. North America Atopic Dermatitis Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Topical
        2. Parenteral
        3. Oral
      3. North America Atopic Dermatitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Canada
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    2. Europe
      1. Europe Atopic Dermatitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
      2. Europe Atopic Dermatitis Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Topical
        2. Parenteral
        3. Oral
      3. Europe Atopic Dermatitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Germany
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. France
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Spain
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Italy
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Russia
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Nordic
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. Benelux
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      12. Rest of Europe
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    3. APAC
      1. APAC Atopic Dermatitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
      2. APAC Atopic Dermatitis Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Topical
        2. Parenteral
        3. Oral
      3. APAC Atopic Dermatitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Korea
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Japan
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. India
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Australia
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Taiwan
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. South East Asia
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. Rest of Asia-Pacific
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Atopic Dermatitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
      2. Middle East and Africa Atopic Dermatitis Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Topical
        2. Parenteral
        3. Oral
      3. Middle East and Africa Atopic Dermatitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Turkey
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Saudi Arabia
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. South Africa
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Egypt
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Nigeria
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Rest of MEA
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    5. LATAM
      1. LATAM Atopic Dermatitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
      2. LATAM Atopic Dermatitis Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Topical
        2. Parenteral
        3. Oral
      3. LATAM Atopic Dermatitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Mexico
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Argentina
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Chile
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Colombia
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Rest of LATAM
        1. Corticosteroids
        2. Calcineurin Inhibitors
        3. PDE4 Inhibitors
        4. Biologics
        5. Others
        6. Topical
        7. Parenteral
        8. Oral
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.